Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application and medical application of punicalagin as PTP1B inhibitor

A technology of punicalagin and inhibitors, which is applied in the field of diabetes and can solve problems such as no clinical research

Inactive Publication Date: 2016-12-07
BEIJING CHINESE MEDICINE HOSPITAL AFFILIATED CAPITAL MEDICAL UNIV +1
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These synthetic compounds have a good hypoglycemic ef

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application and medical application of punicalagin as PTP1B inhibitor
  • Application and medical application of punicalagin as PTP1B inhibitor
  • Application and medical application of punicalagin as PTP1B inhibitor

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application and medical application of punicalagin as a PTP1B inhibitor and further relates to application of punicalagin in preparation of medicine for preventing or treating diseases relevant to protein-tyrosine-phosphatase 1B (PTP1B). Punicalagin serves as a natural active compound in plants and has high success probability in the later research and development process of the medicine.

Description

technical field [0001] The present invention relates to the field of diabetes, in particular to the application of punicalagin as an inhibitor of protein tyrosine phosphatase 1B (PTP1B). Background technique [0002] Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia, which is caused by defective insulin secretion or its biological action, or both. The prevalence of DM is increasing globally. According to the latest statistics from the International Diabetes Federation (IDF), as of 2013, 382 million people around the world suffer from diabetes, and this number is expected to rise to 592 million by 2035. Type 2 diabetes mellitus (T2DM) is the most common form of diabetes, accounting for approximately 90% of diabetes worldwide, and is characterized by hyperglycemia, dyslipidemia, and insulin resistance in metabolic target tissues. Type 2 diabetes can lead to serious complications including kidney failure, blindness, slow wound healing and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7048A23L33/00A61P3/10A61P5/50A61P3/04A61P3/00A61P35/00A61P1/16A61P25/28A61P11/00A61P7/00A61P35/02A61P3/06A61P31/00A61P31/04
CPCA23V2002/00A61K31/7048A23V2200/328A23V2200/332A23V2200/3262A23V2200/322A23V2200/308A23V2200/32A23V2200/314A23V2200/30Y02A50/30
Inventor 徐霄龙刘清泉赵京霞
Owner BEIJING CHINESE MEDICINE HOSPITAL AFFILIATED CAPITAL MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com